MIFH
AZN icon

Migdal Insurance & Financial Holdings’s AstraZeneca AZN Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128M Buy
676,000
+390,000
+136% +$73.4M 0.82% 34
2026
Q1 		$55.9M Buy
286,000
+189,000
+195% +$36.4M 0.48% 48
2025
Q4 		$17.8M Hold
97,000
– – 0.15% 71
2025
Q3 		$14.9M Buy
+97,000
New +$14.7M 0.16% 74

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Migdal Insurance & Financial Holdings's AZN Position: Q2 2026 in Review

Migdal Insurance & Financial Holdings increased its AstraZeneca (AZN) stake by 136% in Q2 2026, buying an estimated $73.4M and bringing the position to 676,000 shares worth $128M. The position accounts for 0.82% of the portfolio, ranked #34.

Migdal Insurance & Financial Holdings first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Migdal Insurance & Financial Holdings held 676,000 shares of AstraZeneca worth $128M as of Q2 2026.
  • Migdal Insurance & Financial Holdings bought 390,000 AstraZeneca shares in Q2 2026, an estimated $73.4M.
  • AstraZeneca made up 0.82% of Migdal Insurance & Financial Holdings's portfolio in Q2 2026, its #34 holding.
  • Migdal Insurance & Financial Holdings first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2026, filed 10 Aug 2026.